Cattinara Hospital, Department of Urology, University of Trieste, Strada di Fiume 447, Trieste, 34149, Italy.
Maggiore Hospital, Department of Infectious Disease, University of Trieste, Piazza dell'Ospitale 1, Trieste, 34125, Italy.
Res Social Adm Pharm. 2021 Jan;17(1):1882-1887. doi: 10.1016/j.sapharm.2020.05.020. Epub 2020 May 27.
Since the beginning of the 2020 Sars-CoV-2 Italian outbreak, healthcare workers have been among the most exposed categories. There is little information about community pharmacists' on occupational exposure, symptoms development, and testing practices in the community pharmacist cohort.
Between April 30th and May 10th, a questionnaire was administered through social media to Italian community pharmacists. From 67000 pharmacists currently working in community pharmacies, 1632 answered the survey.
The survey population reflected the general Italian community pharmacists population in terms of age, gender, and number of co-workers. Protective measures were adopted in up to 99.9% of pharmacies. 624 pharmacists (38.2%) developed at least one COVID-19 related symptom in the period between February 28th and May 10th. Also, 102 pharmacists (6.2%) were tested for COVID-19 and 15, the 15% of the tested population and 0.92% of the whole survey population, resulted positive on nasopharyngeal swab. However, while the number of symptomatic pharmacists decreased, a higher number of tests were performed, thus COVID-19 prevalence among community pharmacists could have been underestimated and is probably intermediate between other healthcare workers and the general population (0.31%).
Community pharmacists have probably been one of the first categories to experience increased contact risk to SARS-CoV-2. COVID-19 prevalence among pharmacists could have been underestimated. In addition, the rates of protection measures adoption might have helped to reduce the spread of COVID-19 among co-workers and the community.
自 2020 年 SARS-CoV-2 意大利疫情爆发以来，医护人员一直是暴露风险最高的群体之一。关于社区药剂师在社区药剂师群体中的职业暴露、症状发展和检测实践，知之甚少。
4 月 30 日至 5 月 10 日期间，通过社交媒体向意大利社区药剂师发放问卷。在目前在社区药房工作的 67000 名药剂师中，有 1632 人回答了调查。
调查人群在年龄、性别和同事人数方面反映了意大利一般社区药剂师的总体情况。高达 99.9%的药房采取了保护措施。在 2 月 28 日至 5 月 10 日期间，有 624 名药剂师（38.2%）出现至少一种与 COVID-19 相关的症状。此外，有 102 名药剂师（6.2%）接受了 COVID-19 检测，其中 15 人（被检测人群的 15%和整个调查人群的 0.92%）鼻咽拭子检测呈阳性。然而，尽管出现症状的药剂师人数有所减少，但进行的检测次数却有所增加，因此社区药剂师中 COVID-19 的患病率可能被低估了，且可能处于其他医护人员和普通人群之间（0.31%）。
社区药剂师可能是第一批接触 SARS-CoV-2 风险增加的人群之一。药剂师中 COVID-19 的患病率可能被低估了。此外，采取保护措施的比率可能有助于减少 COVID-19 在同事和社区中的传播。
